Cite
HARVARD Citation
Manning-Bog, A. et al. (n.d.). 469 Cooperation between checkpoint inhibitors targeting the PD-1/PD-L1 axis and ATRC-101, a novel clinical-stage candidate for the treatment of solid tissue malignancies. Journal for immunotherapy of cancer. pp. A286-A287. [Online].